Chair & Chief Executive Officer
Mr. Glastra was appointed Chair & Chief Executive Officer of the Company’s Board of Directors on May 13, 2021 and has served as the Company’s Chief Executive Officer since September 1, 2016. He joined Novanta Inc. [Nasdaq: NOVT] in 2012 as Group President, and was appointed the Company’s Chief Operating Officer in February 2015. Prior to Novanta, he led and grew global technology businesses in advanced manufacturing and medical end-markets during an 18-year career with Philips [NYSE: PHG], both in Europe as well as Silicon Valley. He most recently served as Chief Executive Officer of Philips’ Entertainment Lighting and as Chief Operating Officer of Philips Lumileds. Prior to that, he held multiple general manager and leadership positions at various Philips divisions, including the Healthcare division. Mr. Glastra also served as Director of Corporate Strategy in the Philips’ corporate headquarters. He started his career as Product Manager of Computed Tomography in the Philips’ Healthcare division in 1994.
Mr. Glastra, a Dutch citizen, holds a Master of Science Degree in Applied Physics from Delft University of Technology, an Advanced Engineering Degree from ESPCI in Paris, France, and an MBA from INSEAD in Fontainebleau, France.
Chief Information Officer
Ms. Betadam was appointed Novanta’s Chief Information Officer in January 2021 and is responsible for strategic direction, leadership, and implementation of enterprise-wide Digital Transformation and Information Technology (“IT”). She joined Novanta [Nasdaq: NOVT] in 2019 as Vice President of Business Applications and was promoted to Senior Vice President, Global IT in March 2020. Ms. Betadam brings 18 years of experience in global transformation initiatives, strategic business planning, merger and acquisition, and change management. Prior to Novanta, Ms. Betadam held the position of Director and Head of IT, Portfolio and Program Management at Splunk, Inc. [Nasdaq: SPLK]. She also held IT management positions within a variety of industries and multi-billion dollar organizations.
Ms. Betadam holds a bachelor’s degree in Computer Science and Applied Arts from San Diego State University, a master’s degree in Computer Science and Engineering (specialization in Information Assurance) from Santa Clara University, and holds a Doctor of Engineering, Engineering Management and Systems Engineering from George Washington University.
Chief Financial Officer
Mr. Buckley joined Novanta [Nasdaq: NOVT] in 2011 as Chief Financial Officer. Prior to joining the Company, Mr. Buckley had a ten-year career at PerkinElmer, Inc. [NYSE: PKI], a provider of technology and services to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets, where he served in several financial positions of increasing responsibility. Most recently, Mr. Buckley served as Vice President and Chief Financial Officer of PerkinElmer’s Environmental Health business. Before that, Mr. Buckley was Chief Financial Officer of PerkinElmer’s Asian operations and served in a number of progressively senior roles in large and global business units. Prior to joining PerkinElmer, Mr. Buckley held management positions with Honeywell International, Inc. [NYSE: HON], most recently in Corporate Development and Investor Relations. Mr. Buckley holds a B.A. in Finance from Manhattanville College and an M.B.A. from University of California Los Angeles (U.C.L.A.).
Chief Accounting Officer and Corporate Controller
Mr. Chang has served as the Company’s Chief Accounting Officer and Corporate Controller since August 2011. Prior to joining Novanta [Nasdaq: NOVT], he worked at EMD Millipore (formerly known as Millipore Corporation) as the Assistant Corporate Controller (2007-2011) and earlier as the Director of Financial Reporting. Prior to that, he was in the Audit and Assurance Services practice of PricewaterhouseCoopers LLP in Boston, Massachusetts (1995–2005), most recently as a Senior Manager. At PricewaterhouseCoopers, he managed and coordinated audit and advisory services to several multinational corporations in a variety of industries. Mr. Chang is a Certified Public Accountant (CPA) and Chartered Global Management Accountant (CGMA).
Mr. Dreyer is Group President of the Vision operating segment. He joined Novanta Inc. [Nasdaq: NOVT] in April of 2018, as Group President of Novanta’s Minimally Invasive Surgery business unit. Prior to joining the company, Mr. Dreyer held the position of Vice President, Applied Microscopy Division for Leica Microsystems, a division of Danaher Corporation [NYSE: DHR]. He joined Leica Microsystems in 2012 as Vice President, Medical Division. From 1999 to 2012 he had an extensive career at Stryker Corporation [NYSE: SYK] with leadership roles in operations, R&D and business management. Mr. Dreyer holds a Dipl-Engineer degree in Management and Engineering from Technical University in Berlin, Germany, an AMSEC Master degree from Ecole Superieure de Paris, and a PhD in Logistics from Technical University in Munich, Germany.
Vice President of Leadership Development and Diversity, Equity, and Inclusion
Ms. Fain joined Novanta [Nasdaq: NOVT] in May 2021 as Vice President of Leadership Development and Diversity, Equity, and Inclusion. She brings over 20 years of experience in leadership development, Diversity, Equity, and Inclusion, and learning and development within the healthcare industry. Prior to joining Novanta, she served in global leadership roles at AstraZeneca [Nasdaq: AZN], a biopharmaceutical company. She was responsible for designing and developing leadership development and learning & development strategies. Ms. Fain also served as the Senior Director, Healthcare Leadership Academy at the Advisory Board Company and served as a coach and advisor to its membership. Before that, she served as a commercial leader for Novartis Pharmaceuticals [NYSE: NVS] where she held multiple sales and marketing leadership roles with increasing responsibilities and in key account management roles.
Ms. Fain holds a B.A. from Kent State University, and an M.S. in Applied Behavioral Science from The Johns Hopkins University, Carey School of Business. Additionally, Ms. Fain served as adjunct faculty at The Johns Hopkins University, School of Nursing. She holds multiple certifications in Diversity, Equity, and Inclusion.
Executive Vice President, Strategy and Business Development
Ms. Sahin joined Novanta [Nasdaq: NOVT] in September 2017 as Vice President, Strategy and Business Development. She brings 20 years of experience in strategic initiatives, acquisitions, and integration activities for life science, medical device, and technology companies. Prior to Novanta, Ms. Sahin was responsible for strategy and business development for the Specialty Diagnostics Group within Thermo Fisher Scientific [NYSE: TMO]. Her prior experience includes senior corporate development roles at Thermo Fisher Scientific, Covidien (acquired by Medtronic [NYSE: MDT]), and Charles River Laboratories [NYSE: CRL]. Earlier in her career, she was a strategy consultant at Bain & Company. Ms. Sahin holds a B.A. in Economics from Yale University, and an M.B.A. from the Wharton School at the University of Pennsylvania.
Executive Vice President, Novanta Growth System and Global Supply Chain
Mr. Webster was appointed Executive Vice President, Novanta Growth System and Global Supply Chain in July 2019. The Novanta Growth System (“NGS”) is a set of common tools and processes that enable performance improvement in all areas of our business including customer satisfaction, gross margins, inventory management, and the efficiency of our manufacturing sites. Mr. Webster joined Novanta [Nasdaq: NOVT] in June 2016 as President and General Manager of Synrad. Prior to Novanta, Mr. Webster had a 25-year career in finance, operations, and general management. He served as Chief Financial Officer at several public and private companies and held various executive leadership roles in the energy, semiconductor, and technology industries with firms including KLA-Tencor [Nasdaq: KLAC], Bechtel, and Xperi [Nasdaq: XPER] (formerly known as Tessera).
Mr. Webster holds a Bachelor of Arts degree in International Economics from Stanford University and a Master of Public Administration degree from Harvard University.
Chief Human Resources Officer
Mr. Young joined Novanta [Nasdaq: NOVT] in April 2015 as Vice President of Human Resources and was appointed Chief Human Resources Officer by the Board of Directors in December 2016. Mr. Young brings more than 20 years of human resources leadership experience in both public and private companies serving Original Equipment Manufacturers of Class I, II & III Medical Devices, Industrial Control Technology and Advanced Materials. His previous roles include Global Human Resource Leader for Hollingsworth & Vose Company and Vice President & Human Resource Officer for CIRCOR International, Inc. [NYSE: CIR]. In addition, Mr. Young served in leadership roles with Lake Region Medical (formerly known as Accellent, Inc.). Mr. Young’s early career experience was in General Human Resource Management with a specialization in Training and Development. Mr. Young holds a B.Sc., Administration of Justice from the School of Liberal Arts, Pennsylvania State University.